Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease

Kalra, Manju; Gloviczki, Péter; Andrews, James C.; Cherry, Kenneth J.; Bower, Thomas C.; Panneton, Jean M.; Bjarnason, Haraldur; Noel, Audra A.; Schleck, Cathy D.; Harmsen, William S.; Canton, Linda G.; Pairolero, Peter C.

doi:10.1016/s0741-5214(03)00331-8

Cited by 172 publications

(145 citation statements)

References 44 publications

Supporting

Mentioning

141

Contrasting

Unclassified

Order By: Relevance

“…Grafting of the superior vena cava grafts using autogenous spiral saphenous vein, autogenous superficial femoral vein or stents (PTFE or GoreTex®) is the treatment of choice for superior vena cava syndrome of benign etiology. (12) Reconstruction with autogenous spiral saphenous vein achieves excellent clinical results and a perviousness index of 80% in the long run. (12) The superficial femoral vein makes a good graft, but has been less frequently used due to the occurrence of thrombosis and distal venous vascular insufficiency at the donor site.…”

Section: Discussionmentioning

confidence: 99%

“…(12) Reconstruction with autogenous spiral saphenous vein achieves excellent clinical results and a perviousness index of 80% in the long run. (12) The superficial femoral vein makes a good graft, but has been less frequently used due to the occurrence of thrombosis and distal venous vascular insufficiency at the donor site. (12) The use of prosthetic materials, as compared to autogenous grafts, presents a shorter patency period and worse clinical results.…”

Section: Discussionmentioning

confidence: 99%

“…(12) The superficial femoral vein makes a good graft, but has been less frequently used due to the occurrence of thrombosis and distal venous vascular insufficiency at the donor site. (12) The use of prosthetic materials, as compared to autogenous grafts, presents a shorter patency period and worse clinical results. Among such materials, PTFE stents are the best, reaching a perviousness index of up to 100% within a year.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Mediastinite esclerosante no diagnóstico diferencial de tumores mediastinais

et al. 2006

View full text Add to dashboard Cite

Sclerosing mediastinitis is a rare disorder characterized by an extensive fibrotic reaction involving the mediastinum. Due to the compression or invasion of mediastinal structures, the disorder mimics neoplasia. We present three cases of superior vena cava syndrome in which sclerosing mediastinitis was confirmed. The pathophysiological process is related to enlarged mediastinal lymph nodes, fibroblast proliferation and collagen deposition. The main causes of sclerosing mediastinitis are histoplasmosis and tuberculosis, both of which are prevalent in Brazil. It is difficult to make an accurate histopathological diagnosis using minimally invasive methods, and there is no effective treatment for this condition. In order to make a definitive diagnosis and resolve the aerodigestive tract obstruction, exploratory surgery is indicated.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Mediastinite esclerosante no diagnóstico diferencial de tumores mediastinais

et al. 2006

View full text Add to dashboard Cite

show abstract

“…Use of long-term anticoagulation therapy is controversial. Endovascular intervention is needed if medical management fails or if there is recurrence of the syndrome [1,3,4]. Copyright: ©2018 Nasser M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.…”

mentioning

confidence: 99%

An under-recognized cause for superior vena cava syndrome

Nasser¹,

Bandeali²,

Farwati³

2017

Glob Surg

View full text Add to dashboard Cite

A 61-year-old African American male with hypertension, endstage renal disease, on haemodialysis since four years. He was referred to cardiology for evaluation of his cardiac status prior to possible renal transplantation. During the time he was on dialysis, he initially had a left subclavian catheter for access. This was removed after an AV fistula was placed in the right arm. Due to thrombosis of the fistula, a right internal jugular tunnelled catheter was inserted and was in place for about three years. His most recent dialysis access was an AV fistula in the left forearm.Upon examination, patient's face was puffy and plethoric. His superficial neck, chest and abdominal wall veins were markedly Correspondence to: Medhat Farwati,

show abstract

“…However, the availability of new flexible intravascular stents, allowing access even to tortuous vessels, provides a new therapeutic approach for patients with vascular problems in diverse specialties. There have been significant declines in the use of SV grafting for the treatment of coronary ostioplasty,12 cerebrovascular disorders,13 superior vena cava syndrome,14 and visceral revascularization15 due to the introduction of angioplasty and stenting techniques. The percutaneous transluminal angioplasty and stenting, however, may develop complications or recurrent symptoms, which may eventually warrant surgical intervention 15.…”

mentioning

confidence: 99%

A Reappraisal of Saphenous Vein Grafting

Yuan

Hua

2011

Annals of Saudi Medicine

View full text Add to dashboard Cite

Autologous saphenous vein grafting has been broadly used as a bypass conduit, interposition graft, and patch graft in a variety of operations in cardiac, thoracic, neurovascular, general vascular, vascular access, and urology surgeries, since they are superior to prosthetic veins. Modified saphenous vein grafts (SVG), including spiral and cylindrical grafts, and vein cuffs or patches, are employed in vascular revascularization to satisfy the large size of the receipt vessels or to obtain a better patency. A loop SVG helps flap survival in a muscle flap transfer in plastic and reconstructive surgery. For dialysis or transfusion purposes, a straight or loop arteriovenous fistula created in the forearm or the thigh with an SVG has acceptable patency. The saphenous vein has even been used as a stent cover to minimize the potential complications of standard angioplasty technique. However, the use of saphenous vein grafting is now largely diminished in treating cerebrovascular disorders, superior vena cava syndrome, and visceral revascularization due to the introduction of angioplasty and stenting techniques. The SVG remains the preferable biomaterial in coronary artery bypass, coronary ostioplasty, free flap transfer, and surgical treatment of Peyronie disease. Implications associated with saphenous vein grafting in vascular access surgery for the purpose of dialysis and chemotherapy are considerable. Vascular cuffs and patches have been developed as an important and effective means of enhancing the patency rates of the grafts by linking the synthetic material to the receipt vessel. In addition, saphenous veins can be a cell source for tissue engineering. We review the versatile roles that saphenous vein grafting has played as well as its current status in therapy.

show abstract

Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease

Cited by 172 publications

References 44 publications

Mediastinite esclerosante no diagnóstico diferencial de tumores mediastinais

Mediastinite esclerosante no diagnóstico diferencial de tumores mediastinais

An under-recognized cause for superior vena cava syndrome

A Reappraisal of Saphenous Vein Grafting

Contact Info

Product

Resources

About